Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 1275Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials
Carolin Haeussler,Anne Assmus
Research Policy.2021;50(2)104155
[DOI]
2Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data
Oktay Yildirim,Matthias Gottwald,Peter Schüler,Martin C. Michel
Frontiers in Pharmacology.2016;7(2)104155
[DOI]
3Challenges of independent clinical research
Javier P. Gisbert,María Chaparro
Gastroenterología y Hepatología (English Edition).2021;44(8)599
[DOI]
4Extension of the primary care research object model (PCROM) as clinical research information model (CRIM) for the learning healthcare system
Wolfgang Kuchinke,Töresin Karakoyun,Christian Ohmann,Theodoros N Arvanitis,Adel Taweel,Brendan C Delaney,Stuart M Speedie
BMC Medical Informatics and Decision Making.2014;14(1)599
[DOI]
5Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles
Ko Un Park,Eleftherios P. Mamounas,Matthew H. G. Katz,Gary Unzeitig,Darren Carpizo,Y. Nancy You,Amanda Francescatti,Kelly K. Hunt,Judy C. Boughey
Annals of Surgical Oncology.2020;27(7)2269
[DOI]
6Mechanisms and funding opportunities in genitourinary cancer clinical research
Christopher W. Ryan
Urologic Oncology: Seminars and Original Investigations.2019;37(5)318
[DOI]
7A Bayesian response-adaptive dose-finding and comparative effectiveness trial
Anna Heath,Maryna Yaskina,Petros Pechlivanoglou,David Rios,Martin Offringa,Terry P Klassen,Naveen Poonai,Eleanor Pullenayegum
Clinical Trials.2021;18(1)61
[DOI]
8Fellow-Initiated Clinical Trials
Yan Liu,Xuming Dai
Journal of the American College of Cardiology.2015;66(3)324
[DOI]
9Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study
Jonathan A Cook,Mathew Baldwin,Cushla Cooper,Navraj S Nagra,Joanna C Crocker,Molly Glaze,Gemma Greenall,Amar Rangan,Lucksy Kottam,Jonathan L Rees,Dair Farrar-Hockley,Naomi Merritt,Sally Hopewell,David Beard,Michael Thomas,Melina Dritsaki,Andrew J Carr
Health Technology Assessment.2021;25(13)1
[DOI]
10Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Anette Blümle,Katharina Wollmann,Karin Bischoff,Philipp Kapp,Szimonetta Lohner,Edris Nury,Kai Nitschke,Jasmin Zähringer,Gerta Rücker,Martin Schumacher
BMC Medical Research Methodology.2021;21(1)1
[DOI]
11Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Pamela S. Combs
BMC Medical Research Methodology.2022;21(1)261
[DOI]
12Investigator clinical trials: How can we ask the question?
Jean-François Schved
Haemophilia.2020;26(S3)20
[DOI]
13A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials
Benjamin Speich,Patricia Logullo,Stefanie Deuster,Ioana R. Marian,Joanna Moschandreas,Ala Taji Heravi,Viktoria Gloy,Matthias Briel,Sally Hopewell
Journal of Clinical Epidemiology.2021;131(S3)70
[DOI]
14The Invisible Hand of Industry
X. Mona Guo,Emma L. Barber
Clinical Obstetrics & Gynecology.2022;65(2)260
[DOI]
15Practices and Attitudes of Swiss Stakeholders Regarding Investigator-Initiated Clinical Trial Funding Acquisition and Cost Management
Stuart McLennan,Alexandra Griessbach,Matthias Briel
JAMA Network Open.2021;4(6)e2111847
[DOI]
16Retos y desafíos de la investigación clínica independiente
Javier P. Gisbert,María Chaparro
Gastroenterología y Hepatología.2021;44(8)599
[DOI]
17Pharmaceutical industry contribution to research is essential but full transparency and guidelines are required
Amir Lass
Human Reproduction.2017;32(10)2147
[DOI]
18Current clinical trials on breast cancer in China: A systematic literature review
Ying Fan,Binghe Xu
Cancer.2020;126(S16)3811
[DOI]
19Determination of a novel antifibrotic small molecule GDC-3280 in human plasma and urine by liquid chromatography tandem mass spectrometry to support its first-in-human clinical trial
Jianshuang Wang,Michael Van Parys,Lin Pan,Yuan Chen,Dorothy Cheung,Janine McKnight,Dennis Milanowski,Xiao Ding,Brian Dean
Biomedical Chromatography.2019;33(4)e4482
[DOI]
20Signal Management in Pharmacovigilance: A Review of Activities and Case Studies
Paul Beninger
Clinical Therapeutics.2020;42(6)1110
[DOI]
21Investigator-initiated clinical trials in the Czech Republic - overview for 2004-2007
Lenka Horavová,Katerina Nebeská,Jana Merhautová,Regina Demlová,Lenka Soucková
Klinická farmakologie a farmacie.2019;32(4)3
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal